ATE486124T1 - Keratinozyten-kulturverfahren und verwendung davon - Google Patents
Keratinozyten-kulturverfahren und verwendung davonInfo
- Publication number
- ATE486124T1 ATE486124T1 AT04767688T AT04767688T ATE486124T1 AT E486124 T1 ATE486124 T1 AT E486124T1 AT 04767688 T AT04767688 T AT 04767688T AT 04767688 T AT04767688 T AT 04767688T AT E486124 T1 ATE486124 T1 AT E486124T1
- Authority
- AT
- Austria
- Prior art keywords
- keratinocytes
- live
- virus
- culture
- culturing
- Prior art date
Links
- 210000002510 keratinocyte Anatomy 0.000 title abstract 4
- 238000012136 culture method Methods 0.000 title 1
- 238000000034 method Methods 0.000 abstract 4
- 210000002845 virion Anatomy 0.000 abstract 3
- 238000012258 culturing Methods 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 241000287828 Gallus gallus Species 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 229940031567 attenuated vaccine Drugs 0.000 abstract 1
- 239000000824 cytostatic agent Substances 0.000 abstract 1
- 230000001085 cytostatic effect Effects 0.000 abstract 1
- 210000001339 epidermal cell Anatomy 0.000 abstract 1
- 210000005175 epidermal keratinocyte Anatomy 0.000 abstract 1
- 210000002950 fibroblast Anatomy 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000011534 incubation Methods 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 230000001902 propagating effect Effects 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 239000012873 virucide Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
- C12N5/0629—Keratinocytes; Whole skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/80—Undefined extracts from animals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/395—Thyroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16351—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0308781A FR2857671B1 (fr) | 2003-07-18 | 2003-07-18 | Nouveau procede de culture de keratinocytes et ses applications |
| PCT/FR2004/001864 WO2005010173A2 (fr) | 2003-07-18 | 2004-07-15 | Procede de culture de keratinocytes et ses applications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE486124T1 true ATE486124T1 (de) | 2010-11-15 |
Family
ID=33548241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04767688T ATE486124T1 (de) | 2003-07-18 | 2004-07-15 | Keratinozyten-kulturverfahren und verwendung davon |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7521218B2 (de) |
| EP (1) | EP1649011B1 (de) |
| JP (1) | JP2007515933A (de) |
| AT (1) | ATE486124T1 (de) |
| CA (1) | CA2532582A1 (de) |
| DE (1) | DE602004029789D1 (de) |
| FR (1) | FR2857671B1 (de) |
| WO (1) | WO2005010173A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2471868C2 (ru) | 2010-02-18 | 2013-01-10 | Закрытое акционерное общество "Научно-исследовательский институт "Аджиномото-Генетика" (ЗАО АГРИ) | Мутантная аденилатциклаза, днк, кодирующая ее, бактерия семейства enterobacteriaceae, содержащая указанную днк, и способ получения l-аминокислот |
| JP6595157B2 (ja) * | 2014-03-04 | 2019-10-23 | 富士フイルム株式会社 | 細胞撮像制御装置および方法並びにプログラム |
| JP7159048B2 (ja) * | 2016-01-04 | 2022-10-24 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 遺伝子修正自己ケラチノサイトを使用する劣性栄養障害型表皮水疱症のための遺伝子療法 |
| CN107129968A (zh) * | 2017-06-18 | 2017-09-05 | 广东博溪生物科技有限公司 | 一种角质形成细胞含血清培养体系及培养方法 |
| CN114292809A (zh) * | 2021-12-31 | 2022-04-08 | 吉林国健生命工程科学技术有限公司 | 含有鸡血清的细胞体外培养用培养基及鸡血清新应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL100386A (en) | 1990-12-24 | 1995-07-31 | Akzo Nv | Suitable free vaccine against virus |
| US5759552A (en) * | 1991-03-07 | 1998-06-02 | Virogenetics Corporation | Marek's disease virus recombinant poxvirus vaccine |
| US5369025A (en) * | 1991-06-28 | 1994-11-29 | The United States Of America As Represented By The Secretary Of Agriculture | Recombinant fowlpox vaccine for protection against Marek's disease |
| WO1994019015A1 (en) | 1993-02-26 | 1994-09-01 | Syntro Corporation | Recombinant fowlpox viruses and uses thereof |
| EP0703294A1 (de) | 1994-07-14 | 1996-03-27 | Akzo Nobel N.V. | Virusimpfstoff gegen Mareksche Krankheit |
| WO1996006160A1 (en) * | 1994-08-24 | 1996-02-29 | Meiji Milk Products Co., Ltd. | Method of culturing avian cells and cell line obtained thereby |
| FR2726003B1 (fr) * | 1994-10-21 | 2002-10-18 | Agronomique Inst Nat Rech | Milieu de culture de cellules embryonnaires totipotentes aviaires, procede de culture de ces cellules, et cellules embryonnaires totipotentes aviaires |
| EP0748867A1 (de) * | 1995-06-12 | 1996-12-18 | Duphar International Research B.V | Marek-Krankheit Vakzine |
| US5833980A (en) * | 1995-10-27 | 1998-11-10 | Board Of Trustess Operating Michigan State University | Sustainable cell line for the production of the Marek's disease vaccines |
| US6410222B1 (en) | 1998-12-14 | 2002-06-25 | Juridical Foundation The Chemosero-Therapeutic Research Institute | In ovo vaccination of marek's disease type I virus |
-
2003
- 2003-07-18 FR FR0308781A patent/FR2857671B1/fr not_active Expired - Fee Related
-
2004
- 2004-07-15 EP EP04767688A patent/EP1649011B1/de not_active Expired - Lifetime
- 2004-07-15 DE DE602004029789T patent/DE602004029789D1/de not_active Expired - Lifetime
- 2004-07-15 WO PCT/FR2004/001864 patent/WO2005010173A2/fr not_active Ceased
- 2004-07-15 CA CA002532582A patent/CA2532582A1/fr not_active Abandoned
- 2004-07-15 US US10/564,964 patent/US7521218B2/en not_active Expired - Fee Related
- 2004-07-15 JP JP2006519965A patent/JP2007515933A/ja active Pending
- 2004-07-15 AT AT04767688T patent/ATE486124T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1649011A2 (de) | 2006-04-26 |
| US20080124356A1 (en) | 2008-05-29 |
| CA2532582A1 (fr) | 2005-02-03 |
| JP2007515933A (ja) | 2007-06-21 |
| WO2005010173A2 (fr) | 2005-02-03 |
| WO2005010173A3 (fr) | 2005-05-26 |
| DE602004029789D1 (de) | 2010-12-09 |
| EP1649011B1 (de) | 2010-10-27 |
| US7521218B2 (en) | 2009-04-21 |
| FR2857671A1 (fr) | 2005-01-21 |
| FR2857671B1 (fr) | 2007-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1108787E (pt) | Producao de vacinas | |
| Ferrari et al. | Establishment and characterization of two new pig cell lines for use in virological diagnostic laboratories | |
| ATE482267T1 (de) | Tierzellen und verfahren für die replikation von influenza viren | |
| HUP0402415A2 (hu) | Eljárás vírusantigén nagy méretekben történő termelésére | |
| MX2007005132A (es) | Medios libres de proteina animal para cultivo de celulas. | |
| DE69535940D1 (de) | Verfahren zur Herstellung von biologischen Produkten in Protein-freiem Kultur | |
| NO20054124L (no) | Dyre-fri celle kultur metode | |
| ES2150938T3 (es) | Produccion mejorada de taxol y taxanos mediante cultivos celulares de especies de taxus. | |
| DE50214416D1 (de) | Vermehrung von viren in zellkultur | |
| ATE479742T1 (de) | Verfahren zur grosstechnischen herstellung von impfstoffen | |
| BR0313559A (pt) | Método para o cultivo de células primárias e para a amplificação de vìrus sob condições isentas de soro | |
| ATE231729T1 (de) | Verfahren zur industriellen herstellung eines japanischen enkephalitis impfstoffes, und so erhaltener impfstoff | |
| RU2012130928A (ru) | Способ культивирования адгезионных клеток | |
| ATE486124T1 (de) | Keratinozyten-kulturverfahren und verwendung davon | |
| ES8104405A1 (es) | Procedimiento para preparar una vacuna de virus de gripe | |
| KR101445433B1 (ko) | 연속 세포주 제조 방법 | |
| Kim et al. | Investigation of the optimal medium and application strategy for foot‐and‐mouth disease vaccine antigen production | |
| EP1517987A4 (de) | Lungenzellen von baumwollratten zur virenkultur | |
| KR102696955B1 (ko) | 무혈청 배지에서 부유배양이 가능한 신규한 Vero 세포주, 이의 제조 방법 및 상기 신규 세포주를 이용한 백신용 바이러스 제조 방법 | |
| EP1739167A4 (de) | Verfahren zur virusproduktion | |
| WO2024260953A1 (en) | A method of culturing lawsonia intracellularis bacteria | |
| JPH11502412A (ja) | 狂犬病ウイルスの複製およびその定量的検出のための細胞系ならびに方法 | |
| CN101205531A (zh) | 表达碱性成纤维细胞生长因子的胎儿肝脏基质细胞株及其应用 | |
| RU2606848C2 (ru) | Способ определения биологической активности вирусов кори, эпидемического паротита и краснухи при производстве ассоциированных препаратов (варианты) | |
| ATE549406T1 (de) | Gentechnisch veränderter mikroorganismus und verfahren zur herstellung einer makrolidverbindung unter verwendung des mikroorganismus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |